We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$48B
AUM Growth
+$2.2B
Cap. Flow
-$554M
Cap. Flow %
-1.15%
Top 10 Hldgs %
34.88%
Holding
1,000
New
81
Increased
310
Reduced
374
Closed
155

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$320M
2
SLB icon
SLB Ltd
SLB
+$129M
3
HWM icon
Howmet Aerospace
HWM
+$110M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
UAA icon
Under Armour
UAA
+$74.4M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$117M
2
ARNC.PRB
Arconic Inc.
ARNC.PRB
+$104M
3
CMCSA icon
Comcast
CMCSA
+$57.7M
4
AET
Aetna Inc
AET
+$54.5M
5
JPM icon
JPMorgan Chase
JPM
+$38.6M

Sector Composition

Rank Sector Weight
1 Technology 18.21%
2 Consumer Discretionary 15.15%
3 Financials 12.69%
4 Healthcare 11.67%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRVL icon
776
CorVel
CRVL
$3.19B
$7K ﹤0.01%
387
-225
-37% -$4.24K
HCKT icon
777
Hackett Group
HCKT
$280M
$7K ﹤0.01%
452
-428
-49% -$6.63K
NHC icon
778
National Healthcare
NHC
$3.43B
$7K ﹤0.01%
117
+22
+23% +$1.4K
RGEN icon
779
Repligen
RGEN
$9B
$7K ﹤0.01%
182
RMR icon
780
The RMR Group
RMR
$321M
$7K ﹤0.01%
125
SCSC icon
781
Scansource
SCSC
$1.16B
$7K ﹤0.01%
185
TGI
782
DELISTED
Triumph Group
TGI
$7K ﹤0.01%
+264
New +$7.91K
USPH icon
783
US Physical Therapy
USPH
$1.16B
$7K ﹤0.01%
99
UTL icon
784
Unitil
UTL
$981M
$7K ﹤0.01%
149
+69
+86% +$3.46K
NWLI
785
DELISTED
National Western Life Group, Inc. Class A
NWLI
$7K ﹤0.01%
20
AXE
786
DELISTED
Anixter International Inc
AXE
$7K ﹤0.01%
93
-330
-78% -$24.3K
ESL
787
DELISTED
Esterline Technologies
ESL
$7K ﹤0.01%
+92
New +$7.56K
XOXO
788
DELISTED
Xo Group Inc
XOXO
$7K ﹤0.01%
391
-125
-24% -$2.43K
HAWK
789
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$7K ﹤0.01%
190
-460,353
-100% -$16.6M
DAKT icon
790
Daktronics
DAKT
$1.05B
$6K ﹤0.01%
673
-430
-39% -$4.25K
VIVO
791
DELISTED
Meridian Bioscience Inc
VIVO
$6K ﹤0.01%
435
-406
-48% -$5.94K
AGX icon
792
Argan
AGX
$8.28B
$5K ﹤0.01%
100
TRMK icon
793
Trustmark
TRMK
$2.79B
$5K ﹤0.01%
153
ANIK icon
794
Anika Therapeutics
ANIK
$270M
$4K ﹤0.01%
79
DX
795
Dynex Capital
DX
$3.18B
$4K ﹤0.01%
171
-317
-65% -$6.79K
NPK icon
796
National Presto Industries
NPK
$987M
$4K ﹤0.01%
45
-31
-41% -$3.38K
OFG icon
797
OFG Bancorp
OFG
$2.24B
$4K ﹤0.01%
464
PFC
798
DELISTED
Premier Financial Corp. Common Stock
PFC
$4K ﹤0.01%
144
BSL
799
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
$3K ﹤0.01%
167
-105,876
-100% -$1.84M
TCBK icon
800
TriCo Bancshares
TCBK
$1.84B
$3K ﹤0.01%
68
-21
-24% -$862

Similar funds

Loomis, Sayles & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Loomis, Sayles & Company held 1,000 positions worth $48B, up 4.8% from $45.9B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loomis, Sayles & Company's Q4 2017 filing shows 81 new, 310 increased, 374 reduced and 155 closed positions. Its largest new stake was Under Armour: 5,152,381 shares worth $74.3M. The largest sale was Alibaba, an estimated $117M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q4 2017 buy was Under Armour: 5,152,381 shares worth $74.3M.
  • Loomis, Sayles & Company added most to Oracle in Q4 2017, an estimated $320M increase.
  • Loomis, Sayles & Company's biggest Q4 2017 reduction was Alibaba, cutting an estimated $117M.
  • Loomis, Sayles & Company fully exited Arconic Inc. in Q4 2017, selling an estimated $104M.
  • Loomis, Sayles & Company's ten largest holdings make up 35% of its $48B portfolio in Q4 2017.
  • Loomis, Sayles & Company opened 81 new positions and closed 155 in Q4 2017.
  • Loomis, Sayles & Company's portfolio value rose 4.8% quarter-over-quarter to $48B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.